The program’s unique construct allows it to be positioned as a core component of a client‘s population health management strategy. By integrating the program at a case- and data-management level with a client’s other benefits, the program can address comorbid behavioral health concerns and help the plan treat members holistically.
The program is proven to reduce the average client’s outpatient mental health and substance abuse (MHSA) claims by over 30%. In addition, CuraLinc will impact inpatient and residential treatment costs by guiding members with acute MHSA conditions to the most appropriate and cost-effective level of treatment within the health plan at the point of entry. For more information, about CuraLinc’s ability to have a positive impact on costs, click here to access the Financial Offset Dashboard.
The program, which is based on the foundation of an innovative EAP model, has a significant and measurable impact on employee productivity, absenteeism, and condition-specific outcomes from participants who present with depression or alcohol use/abuse.
Every feature of CuraLinc’s behavioral health solution, including the phone number, website, intake greeting, and employee-facing promotional materials, can be tailored to suit the brand of the partner.
Although EAPs have long been a resource for the early identification and treatment of MHSA issues, CuraLinc's unique model can also be positioned to identify physical health concerns before they manifest into high-dollar claims.